2021 annual financial data
ResMed 2021 Net margin
Direct answer
Net margin was 14.84%.
Operating income was 903,678,000 USD and net income was 474,505,000 USD.
Operating cash flow was 736,718,000 USD.
Get free ResMed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,196,825,000 USD
- Operating income
- 903,678,000 USD
- Net income
- 474,505,000 USD
- Operating cash flow
- 736,718,000 USD